Overview

CHAI has worked with government and private health sector partners in China since 2004. From 2004 to 2010, CHAI worked with China's National Health Commission (NHC) to support the government in scaling up HIV/AIDS care and treatment nationally and provincially. From 2010 to date, CHAI has been continuously supporting Chinese pharmaceutical and healthcare commodity manufacturers to participate in the global health market by providing market intelligence and business planning support, with the goal of increasing overall access to quality, affordable health commodities in low-and middle-income countries. In 2022, CHAI established a representative office in China’s Hainan province to support the public health system to prevent and control infectious and non-communicable diseases, including a recently launched pediatric cancer project. At the same time, we are exploring ways to facilitate new relationships between Chinese entities, African and Southeast Asian governments, foreign aid agencies, think tanks, academic and research institutions, and other stakeholders in global health to provide high quality commodities, technical assistance, expertise, and resources from China.

Results

8,000+

people living with HIV received treatment in high-burden provinces between 2006 and 2010

40+

Chinese pharmaceutical and health commodity suppliers provided with market intelligence and business planning support to help deliver health commodities in low-and middle-income countries

US$1

HIV self-test deal negotiated with Chinese manufacturer Wondfo and MedAccess to improve testing access to ~8.1 million people in low- and middle-income countries

Our Donors

Join Our Team

CHAI is looking for dynamic and self-motivated individuals who are committed to strengthening health systems around the world and expanding access to care and treatment of HIV/AIDS, malaria, and other illnesses.

Join Our Team

CHAI is looking for dynamic and self-motivated individuals who are committed to strengthening health systems around the world and expanding access to care and treatment of HIV/AIDS, malaria, and other illnesses.

Back To Top